FDA OKs return of Covidien's Pipeline embolism device

Covidien says it plans to get its recalled Pipeline brain embolism device back on the market immediately, after the FDA approved manufacturing changes aimed at correcting the problem that prompted the recall.

Covidien, Food & Drug Administration (FDA)

News Well, Neurovascular repair, Recalls, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ljMGo7